Prevents HBV Reactivation with Tenofovir in Anti-HBC...

Prevents HBV Reactivation with Tenofovir in Anti-HBC Positive Patients with Hematologic Malignancies Treated with Rituximab. Results Final Visit 18-Months (Preblin Study)

Buti, M., Manzano, M.L., Morillas, R.M., García-Retortillo, M., Martín, L., Prieto, M., Gutiérrez, M.L., Suárez, E., Gil-Ares, F., López, J., Castillo, P., Rodríguez, M., Zozaya, J.M., Simón, M.A., Mo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
64
Year:
2016
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(16)00552-3
File:
PDF, 54 KB
english, 2016
Conversion to is in progress
Conversion to is failed